Metabolic Disease Research, Abbott Laboratories, Dept 4CB, Bldg. AP-10, Rm. L-14, 100 Abbott Park Road, Abott Park, IL 60064-6098, USA. james.link@abbott.com
Abstract:
The optimization of a series of nonsteroidal glucocorticoid modulators is reported. Potent selective GR ligands that have improved metabolic stability were discovered typified by the subnanomolar acid 12 (GR binding IC(50)=0.6 nM).